Detalhe da pesquisa
1.
Thrombus in the left atrial appendage in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants in clinical practice-A multicenter registry.
J Cardiovasc Electrophysiol
; 31(8): 2005-2012, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32458520
2.
Oral anticoagulation therapy in atrial fibrillation patients at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish multicenter register of atrial fibrillation (POL-AF).
Kardiol Pol
; 82(1): 37-45, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38230462
3.
Risk of left atrial appendage thrombus in older patients with atrial fibrillation.
Arch Med Sci
; 19(6): 1721-1730, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058707
4.
Temporal Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients between 2004 and 2019.
Int J Environ Res Public Health
; 19(9)2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35564979
5.
Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney disease.
Cardiol J
; 29(2): 205-215, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-32207840
6.
Association of Hyperuricemia with Impaired Left Ventricular Systolic Function in Patients with Atrial Fibrillation and Preserved Kidney Function: Analysis of the POL-AF Registry Cohort.
Int J Environ Res Public Health
; 19(12)2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35742536
7.
Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?-Results of the Polish Atrial Fibrillation (POL-AF) Registry.
Int J Environ Res Public Health
; 19(19)2022 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36231257
8.
Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in secondary stroke and systemic embolism prevention.
Cardiol J
; 28(6): 896-904, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-31313276
9.
Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry.
J Clin Med
; 10(19)2021 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34640629
10.
Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry.
J Clin Med
; 10(5)2021 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33807883
11.
Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry.
J Clin Med
; 10(7)2021 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33804992
12.
Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry Study.
J Clin Med
; 10(9)2021 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33922386
13.
Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines-data from the POLish Atrial Fibrillation (POL-AF) Registry.
Cardiovasc Diagn Ther
; 11(1): 14-27, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33708474
14.
Tumors of the right atrium and the inferior vena cava operated in deep hypothermic circulatory arrest.
Pol Przegl Chir
; 92(4): 17-22, 2020 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32908013
15.
Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience.
Medicine (Baltimore)
; 99(29): e21209, 2020 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702889
16.
Factors determining elective cardioversion preceded by transesophageal echocardiography: experiences of 2 cardiology centers.
Pol Arch Intern Med
; 130(10): 837-843, 2020 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785205
17.
Prevalence and risk factors of left atrial thrombus in patients with atrial fibrillation and lower class (IIa) recommendation to anticoagulants.
Cardiovasc Diagn Ther
; 10(4): 717-724, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32968628
18.
Left Atrial Appendage Thrombus Formation Despite Continuous Non-Vitamin K Antagonist Oral Anticoagulant Therapy in Atrial Fibrillation Patients Undergoing Electrical Cardioversion or Catheter Ablation: A Comparison of Dabigatran and Rivaroxaban.
Cardiol Res Pract
; 2020: 1206402, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33014453
19.
Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial Fibrillation.
Cardiovasc Ther
; 2020: 3501749, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32411299
20.
Does the CHA2DS2-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?
Medicine (Baltimore)
; 99(25): e20570, 2020 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32569181